Villamor, Erlinda N.

HRN: 20-49-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/25/2022
07/02/2022
IV
4.5gram As LD
As Loading Dose
Septicemia
Waiting Final Action 
06/25/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/25/2022
07/02/2022
IV
2.25g
Q8hrs
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: